{"id":"W2804248319","doi":"10.1093/ecco-jcc/jjy047","title":"Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Internal medicine; Placebo; Ulcerative colitis; Incidence (geometry); Respiratory tract infections; Inflammatory bowel disease; Discontinuation; Hazard ratio; Gastroenterology; Confidence interval; Disease; Respiratory system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05551461,0.001049235,0.003789052,0.001344939,0.0003388513,0.002212184,0.0009555134,0.001627995,0.003282342],"category_scores_gemma":[0.07397918,0.000504026,0.009584515,0.002240897,0.0007721794,0.001559188,0.001002374,0.00216996,0.0003370641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008232359,"about_ca_system_score_gemma":0.001304055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000278431,"about_ca_topic_score_gemma":0.000587321,"domain_scores_codex":[0.9515911,0.03467551,0.006766937,0.002244415,0.004075336,0.000646625],"domain_scores_gemma":[0.8901843,0.07139996,0.02892597,0.003913599,0.004184003,0.001392161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3943206,0.0009808097,0.09693927,0.0518248,0.2191413,0.0003081846,0.0003387212,0.006332593,0.001983182,0.001581063,0.007973399,0.2182762],"study_design_scores_gemma":[0.253639,0.07198601,0.3809333,0.0145781,0.2181115,0.002083923,0.000474143,0.008212588,0.002290388,0.008297003,0.03908985,0.0003043148],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3811442,0.5832359,0.008254469,0.00394285,0.0007593815,0.004059106,0.01092589,0.0001520335,0.007526048],"genre_scores_gemma":[0.9346285,0.04991642,0.002416711,0.002285435,0.0006396961,0.003239245,0.006179753,0.0000543025,0.0006400245],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05551461,"threshold_uncertainty_score":0.2935929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03450278200723733,"score_gpt":0.3534096194753521,"score_spread":0.3189068374681148,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}